Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone and Heparin in COVID-19 Pneumonia
NCT04485429Phase 3Withdrawn
- Sponsor
- Instituto D’Or de Pesquisa e Ensino
- Start
- Jul 2020
- Primary completion
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone injection, heparin in COVID-19 pneumonia, sponsored by Instituto D’Or de Pesquisa e Ensino. Planned start Jul 2020; status: withdrawn.
02
Drugs
methylprednisolone injectionheparin
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04485429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04485429.